ADCT
ADC Therapeutics·NYSE
--
--(--)
--
--(--)
ADCT Filings
Filing Date
Form Description
Form Type
2025-12-15
Form EFFECT - Notice of Effectiveness
2025-12-15 ·
Form EFFECT - Notice of Effectiveness
2025-12-12
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-12 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-09
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2025-12-09 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2025-12-09
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-12-09 ·
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
2025-12-05
Form 8-K - Current report
Key Events
2025-12-05 · Key Events
Form 8-K - Current report
2025-11-13
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-13 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-10
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript
Earnings Call
2025-11-10 · Earnings Call
ADC Therapeutics SA (ADCT) Q3 2025 Earnings Call Transcript
